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Abstract
Glutamate receptor subunit 4 (GluA4) is highly expressed by neural cells sensitive to excitotoxicity,
and is the predominant subunit expressed by oligodendrocyte precursor cells (OPC) during a key
period of vulnerability to hypoxic-ischemic injury. Therefore, transcriptional networks downstream
of excitotoxic GluA4 activation represent a promising area for therapeutic intervention. In this
work, we identify the CCAAT binding transcription factor NF-Yb as a novel transcriptional regula-
tor of Gria4 (GluA4 gene), and a controller of excitotoxic death in the oligodendroglial lineage. We
describe a novel regulatory region within Gria4 containing CCAAT sequences whose binding by
NF-Yb is regulated by excitotoxicity. Excitotoxicity-induced alterations in NF-Yb binding are asso-
ciated with changes in Gria4 transcription, while knockdown of NF-Yb alters the transcription of
reporter constructs containing this regulatory region. Data from immortalized and primary OPC
reveal that RNAi and pharmacological disruption of NF-Yb alter Gria4 transcription, with the latter
inducing apoptosis and influencing a set of apoptotic genes similarly regulated during excitotoxic-
ity. These data provide the first definition of a trans-acting mechanism regulating Gria4, and
identify the NF-Y network as a potential source of pharmacological targets for promoting OPC
survival.
K E YWORD S
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1 | INTRODUCTION
Oligodendrocyte precursor cells (OPC) express AMPA-type glutamate
receptors (AMPAR) whose activation in the healthy CNS has been
shown to influence various functions including migration, proliferation,
differentiation and survival (Fannon, Tarmier, & Fulton, 2015; Gallo
et al., 1996; Gudz, Komuro, & Macklin, 2006; Kougioumtzidou et al.,
2017; Yuan, Eisen, McBain, & Gallo, 1998). AMPAR also mediate injury
to these cells under pathological conditions. In the developing rodent
CNS, hypoxic-ischemic excitotoxicity disrupts the formation of myelin
through excitotoxic actions on OPC AMPAR (Follett, Rosenberg, Volpe,
& Jensen, 2000), while in the adult CNS, inflammatory white matter
injury and associated neurological dysfunctions, are linked to AMPAR-
mediated injury responses (Groom, Smith, & Turski, 2003; Kanwar,
Kanwar, & Krissansen, 2004; Pitt, Werner, & Raine, 2000).
AMPAR are heterotetrameric assemblies containing various
arrangements of GluA subunits 1–4 (GluA1–4). OPC express all four
subunits, although GluA1 represents a minor contributor compared
with GluA2–4 in vitro (Hossain, Liu, Fragoso, & Almazan, 2014; Itoh
et al., 2002), and appears to be entirely absent from OPC in vivo (Kou-
gioumtzidou et al., 2017). Activation of OPC AMPAR provokes an
influx of Ca21 (Ge et al., 2006; Haberlandt et al., 2011; Hamilton,
Vayro, Wigley, & Butt, 2010; Itoh et al., 2002) that can mediate excito-
toxic injury in vitro (Alberdi, Sanchez-Gomez, Marino, & Matute, 2002;
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Deng, Rosenberg, Volpe, & Jensen, 2003; Li & Stys, 2000; Sanchez-
Gomez & Matute, 1999). These observations suggest that a substantial
number of OPC AMPAR lack GluA2 subunits since inclusion of this
subunit limits the permeability of AMPAR to Ca21 (Geiger et al., 1995;
Hollmann, Hartley, & Heinemann, 1991). In support of this, cultured
OPC express high levels of GluA3 and 4 (Hossain et al., 2014; Itoh
et al., 2002) which may assemble to form Ca21 permeable AMPAR,
and GluA4 is the predominant subunit expressed by OPC in the devel-
oping white matter of rodents and humans (Talos, Fishman, et al.,
2006; Talos, Follett, et al., 2006). Importantly, the timing of GluA4
expression in these systems corresponds with an established window
of vulnerability during which OPC are selectively injured by hypoxic-
ischemic conditions (Back et al., 2002; Back et al., 2001; reviewed in
Fern, Matute, & Stys, 2014), and GluA4 is highly expressed in neural
cells vulnerable to excitotoxic cell death (Page & Everitt, 1995). GluA4
signalling is therefore strongly connected to excitotoxicity.
Excitotoxic injury induces OPC and oligodendrocyte cell death
through stress-induced apoptotic pathways involving the Bcl-2 family
(Ness, Romanko, Rothstein, Wood, & Levison, 2001; Ness, Scaduto, &
Wood, 2004; Sanchez-Gomez, Alberdi, Ibarretxe, Torre, & Matute,
2003; Sanchez-Gomez, Alberdi, Perez-Navarro, Alberch, & Matute,
2011; Simonishvili, Jain, Li, Levison, & Wood, 2013). These processes
are tightly regulated by the expression of pro- and anti-apoptotic Bcl-2
genes (Kumar & Cakouros, 2004; Riley, Sontag, Chen, & Levine, 2008),
thus the transcriptional networks stimulated by excitotoxic injury repre-
sent promising targets for therapies aiming to reduce excitotoxic injury
and cell death. In the context of OPC the transcriptional events associ-
ated with GluA4 are of particular interest due to its prominent expres-
sion in these cells, and its links to the induction of excitotoxic cell death
(Page & Everitt, 1995; Santos et al., 2006). Based on this premise we
used an excitotoxic injury model in the Oli-neu cell line (Jung et al.,
1995) and primary OPC (pOPC) to identify subunit B of the nuclear fac-
tor Y complex (NF-Yb) as a regulator of GluA4 transcription and cell sur-
vival in oligodendroglia. Using a combination of ChiP, qPCR, Western
blot and reporter assays we show that excitotoxic AMPAR stimulation
alters NF-Yb binding to a novel Gria4 regulatory region, leading to com-
plementary alterations in the levels of GluA4 mRNA and protein. We
also provide data highlighting the therapeutic potential of the NF-Y
transcriptome, with siRNA and pharmacological-mediated disruption of
the NFY pathway compromising oligodendroglial viability and regulating
similar apoptotic genes to those influenced by excitotoxic injury.
2 | MATERIALS AND METHODS
2.1 | Cell culture
Oli-neu cells were kindly provided by Prof Jacqueline Trotter (University
of Mainz). Oli-neu cells were cultured in Sato medium containing 1%
horse serum (Trotter, Bitter-Suermann, & Schachner, 1989) and grown
in 5% CO2 at 378C. All experiments were carried out with cells at pas-
sage 5 after thawing. Cultures of pOPC were prepared from the neocor-
tices of C57BL6/J mice aged 1–4 days using the protocol described by
O’Meara, Ryan, Colognato, and Kothary (2011). Mixed glial cultures
were maintained for 9 days (5% CO2 at 378C) in DMEM containing 10%
FBS and insulin (2 mg/ml) before isolation of pOPC by the shake-off
method. Isolated pOPC were seeded into poly-L-Lysine coated culture
wells at a density of 1.0–5.0 3 105 cells/well and maintained in OPC
medium. OPC medium consisted of DMEM:F12 supplemented with 1%
N2, 1% B27, 2 mM L-Glutamine, 1% PC-ST, 20 ng/ml rhFGF2, 100 ng/
ml IGF1, 20 ng/ml PDGF-AA, and 3.6 ng/ml Hydrocortisone. pOPC cul-
tures were used for experiments between 1 and 2 days in vitro.
2.2 | Drugs
Stock solutions of L-glutamate (100 mM, Sigma-Aldrich Company Ltd,
Dorset, UK) and AMPA (100 mM, Abcam, Cambridge, UK) were prepared
in distilled water, while cyclothiazide (CTZ, 100 mM, Bio-Techne Ltd/
R&D Systems, Abingdon, UK) and Garcinol (10 mM, Tocris Bioscience,
Abingdon, UK) were prepared in DMSO. Drugs were diluted in Sato
medium for application to Oli-neu cells or OPC medium for experiments
using pOPC. AMPA was applied with CTZ (AMPA/CTZ; both at 100 mM)
for 5 hr to induce excitotoxicity (Alberdi et al., 2002), or at 200 mM (with-
out CTZ) for 24 hr for non-pathological AMPAR stimulation (AMPA24h;
Yuan et al., 1998). In experiments using pOPC CTZwas applied at 50 mM.
Garcinol was used at 10 mM for gene expression, Western blot, and ChIP
experiments. This concentration was selected based on pilot studies
examining treatment with log concentrations of Garcinol (1–1,000 mM),
in which concentrations >10 mM caused catastrophic cell detachment
and death (data not shown). BrdU (Sigma-Aldrich Company Ltd) stocks
were prepared as described by Fannon et al. (2015).
2.3 | Trypan blue cell viability assay
For viability assays Oli-neu were seeded into 6-well plates at a density
of 5 3 105 cells/well, while pOPC were cultured in 12-well plates at a
density of 5 3 104 cells/well. 24 hr after seeding cells were treated
with L-glutamate, CTZ, or AMPA/CTZ for 5 hr, then trypsinized, stained
with 0.04% trypan blue (Sigma-Aldrich) and counted on a haemocytom-
eter to quantify % viability. Data were collected in triplicate from five
independent cell cultures by an experimenter masked to the treatment.
2.4 | Antibodies
Antibodies used in this study are detailed in Supporting Information
Table S1. Specificity for immunopositive signals was determined in con-
trol samples incubated with secondary antibodies alone.
2.5 | Immunocytochemistry, plasma membrane
labelling and imaging
Immunofluorescent staining was performed using a protocol previously
used in our lab to label brain slices (Fannon et al., 2015). The protocol
was adapted for use on Oli-neu cells as follows. Oli-neu were grown in
8-well chamber slides (Corning Falcon, Wiesbaden, Germany) at a den-
sity of 33 104 cells/well, and the fixation, blocking, and secondary anti-
body incubation steps were reduced to 20 min, 1 hr, and 1 hr,
respectively. Chamber slides were coverslipped with Vectashield
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containing DAPI (Vector Laboratories, Peterborough, UK). CellMask
Deep Red (Molecular Probes, Eugene, OR; Thermo Fisher Scientific,
Waltham, MA) was used to localize GluA4 to plasma membranes of Oli-
neu cells. Live cells were incubated in CellMask (2.5 ml/ml) diluted in
Sato medium for 5 min (5% CO2, 378C) and immediately fixed in PFA,
permeabalized with an optimized protocol (0.2% Tween-20 for 10 min)
which preserved CellMask signal while allowing reasonable labeling of
GluA4. GluA4 was then detected as described above, except for omis-
sion of Triton-X100 in the blocking and carrier solutions. Slides were
imaged on an inverted microscope (Zeiss Axiovert 200, Zeiss, Oberko-
chen, Germany) equipped with a differential spinning disk confocal
module as described previously (Fannon et al., 2015).Objectives used
were 203 (Air, 0.5 N.A.) and 1003 (oil, 1.3 N.A.). AMPAR immunofluo-
rescence was imaged in confocal mode, while proliferation studies were
imaged in the wide-field configuration. Cleaved caspase-3 labeling was
imaged at 203 on Axioplan 200 epi-fluorescent microscope equipped
with an AxioCam HRc (all from Zeiss, Herefordshire, UK).
2.6 | Proliferation and apoptosis studies
Cells were seeded into 8-well chamber slides at a density of 3 3 105
and allowed to settle for 24 hr prior to treatment with AMPA/CTZ, fol-
lowed by exposure to BrdU (10 mM) for 7 hr. For AMPA24h experi-
ments BrdU treatments were introduced during the last 7 hr of
treatment. BrdU was detected as previously described (Fannon et al.,
2015) and proliferation quantified as the % DAPI1/BrdU1 cells from
five randomly selected fields/well from seven to eight independent
well replicates. Apoptosis was examined by immunofluorescent label-
ling for cleaved Caspase3 24 hr after treatment of cells with Garcinol
(5 hr, 10 mM), or the vehicle control (DMSO, 0.001%). Data were quan-
tified as % cleaved caspase-31/DAPI1 nuclei from four randomly
selected areas of each well (n 5 4/group).
2.7 | GcCamp5 Ca21 imaging
A recombinant Semlikiforest Virus (SFV) vector derived from strain A7
(74) was constructed to deliver GcAMP5 (Akerboom et al., 2012) to
Oli-neu cells (Ehrengruber et al., 2003; Fannon et al., 2015). GcAMP5
cDNA (gift from Dr Lin Tian, University of California, Davis) was cloned
into pSFV(A774nsP) and infectious SFV(A774nsP)-GcAMP5 (SFV-
GcAMP5) particles generated in BHK cells using method a described
by Ehrengruber, Schlesinger, and Lundstrom (2011). Oli-neu cells in
35 mm imaging dishes (MatTek Corporation, Ashland, MA) were
infected by treatment with Sato medium containing a 1:100 dilution of
the un-purified SFV-GcAMP5 preparation (7.86 3 105 infectious units/
ml, 1 hr, 378C/5% CO2). Cells were imaged the following day using the
spinning disk module in confocal mode (203, 485 nm excitation filter,
560 nm emission filter). Cells were perfused with medium via a peristal-
tic pump enabling delivery and removal of CTZ and AMPA/CTZ solu-
tions. Solutions within the imaging dish were maintained at 348C via an
inline heater (Bioscience Tools, San Diego, CA) coupled to the perfu-
sion setup. GcAMP5 signals were captured one frame/10 s through
the following sequence: 5 min CTZ alone (baseline), 5 min AMPA/CTZ,
5 min CTZ alone. Mean signal intensity was measured using ImageJ
(Schneider, Rasband, & Eliceiri, 2012), and changes in GcAMP5 quanti-
fied by normalizing to the mean baseline fluorescence (DF/F).
2.8 | RNA and protein extraction
Five independent cultures of Oli-neu cells were seeded into T25
(13 106 cells/flask) in duplicate and left to adhere overnight. Duplicate
flasks received the following treatment pairings: CTZ alone or AMPA/
CTZ; Control Sato or AMPA24h; DMSO control or Garcinol (see Section
2.2 for treatment durations). Trypsinized samples were divided, washed
with ice cold PBS, and RNA extracted from one sample using the
RNeasy mini kit (Qiagen, Manchester, UK).The other sample was incu-
bated for 30 min on ice with protein lysis buffer consisting of 20 nM
Tris HCL pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 1% Igepal
and 5 ml/ml of protease inhibitor. Protein levels were then quantified
using the RC/DC assay (Bio-Rad, Hemel Hempstead, UK) and RNA/
protein samples were stored at 2708C pending further analysis. RNA
extractions from pOPC were performed using an identical protocol.
2.9 | Gene expression analysis and NF-yb knockdown
RNA samples were reverse transcribed using the Tetro cDNA synthesis
kit (Bioline Reagents Ltd, London, UK) using the random hexamer pri-
mers provided. qPCR was performed using a Bio-rad iQ5 PCR detec-
tion system with SYBR green PCR mastermix (Thermo Fisher Scientific,
Paisley, UK, see Supporting Information Table S2 for qPCR primer
sequences). Primer efficiency was tested using a 7-point standard
curve, and gene expression calculated using the 2-DDCt method and
normalized to the expression of b-actin. For NF-Yb knockdown, Oli-
neu cells were transfected with commercially available siRNA against
NF-Yb (siNF-Yb, Qiagen Mm Nfyb1 FlexiTube siRNA SI01327207) or a
negative control siRNA (siControl, Qiagen SI03650325). Knockdown of
NF-Yb in pOPC was achieved by transfection of a cocktail of four
siRNA against NF-Yb (siNF-Yb multi, Qiagen FlexiTube Genesolution
siRNA GS18045). For Olie-neu cells siRNA constructs (5–50 nmol)
were mixed with FuGENE HD (Promega Corporation, Madison, WI) at
a ratio of 1:4 (mg cDNA:ml reagent), and cells transfected with the
resulting complexes. NF-Yb gene expression was examined 24 and
48 hr after transfection. In experiment using pOPC, siRNA constructs
(40 nM) were mixed with Lipofectamine RNAiMAX (Thermo fisher Sci-
entific). pOPC were incubated in the Liposome-siRNA complexes for
6 hr, after which they were washed with OPC medium, and then cul-
tured for a further 24 hr prior to use in experiments.
2.10 | Western blot
Extracted proteins were separated by SDS-Page using the Xcell sure
lock mini-cell system (Thermo Fisher Scientific), and then transferred
onto PVDF membranes (Immobilion-P, Merck Millipore, Watford, UK).
Membranes were then incubated for 1 hr at room temperature in
blocking medium (5% non-fat milk dissolved in TBST [0.05 M Tris,
0.15 M NaCl, pH 7.2, 0.1% (v/v) Tween20]), before incubation in pri-
mary antibodies overnight at 48C with constant agitation. After
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washing in TBST membranes were incubated in secondary antibodies
for 1 hr at room temperature. All antibodies were diluted in blocking
medium (see Supporting Information Table S1 for details of antibodies).
2.11 | Chromatin immunoprecipitation (ChIP)
ChIP experiments quantifying NF-Yb binding to the Gria4 intronic regu-
latory region were performed in accordance with previously published
methods (Weaver et al., 2004; Zhang et al., 2010). Briefly, Oli-neu cells
were plated at a density of 1 3 106 cells in T25 flasks and allowed to
adhere overnight. Duplicate flasks received the following treatment pair-
ings: CTZ alone or AMPA/CTZ; Control Sato or AMPA24h; DMSO con-
trol or Garcinol. Following these treatments cells were fixed in 1% PFA
at RT for 10 min before the addition of 0.125 M glycine. The medium
was then removed and saved and cells washed in ice cold PBS before
collection with cell scrapers in Farnham lysis buffer (plus protease inhibi-
tors). The stored cell medium and collected cells were then combined
and pelleted at 48C, before sonication (Soniprep 150 plus, MSE, Ltd, Lon-
don, UK, [1 3 10 s maximum power]), followed by centrifugation of the
resulting suspension and further sonication of supernatants at 73 10 s/
20 amp. Supernatants were de-crosslinked and purified to determine
consistent fragment sizes on a 1.5% agarose gel. Chromatin was immu-
noprecipitated with an antibody against NF-Yb (Supporting Information
Table S1) while antibodies against RNA POL and normal mouse IgG
were used for positive and negative controls respectively. Samples were
then prepared for DNA elution by hydrolysis of crosslinks and all input-
digested DNA and output DNA purified using the Qiaquick PCR purifica-
tion kit (Qiagen). Ratios of output DNA:input DNA were determined by
qPCR with the primers detailed in Supporting Information Table S2. All
ChiP experiments were performed on triplicate samples derived from
five independent Oli-neu cell cultures except for Garcinol treated groups
where triplicate samples were assessed in four independent cultures.
2.12 | Luciferase assays
Reporter constructs containing either the 822 bp Gria4 regulatory
sequence (wtGria4), or a version with NF-Y binding site mutations
(DGria4, see Supporting Information Table S3 for details) were synthe-
sized commercially (GeneWiz, LLC, South Plainfield, NJ) and inserted
into pGL4.23[Luc2/minP] (Promega Corporation). Reporter constructs
were transfected (FuGENE HD, Promega Corporation) into Oli-neu cells
seeded in opaque 96-well plates at a density of 8 3 104 cells/well.
Transfections involved 235 ng/well of the normalizing vector pGL4.74
[hRluc/TK] plus 290 ng/well of either wtGria4, DGria4, or the empty
pGL4.23[Luc2/minP] vector. Reporter activity was initiated 24 hr later
by the Promega DLR assay (Promega Corporation) and recorded on a
luminometer (Centro LB 960, Bethold Technologies, Harpenden, UK).
2.13 | Transcriptome analysis
Transcriptomic profiling was carried out on extracted RNA (Qiagen,
Crawley, UK) after the quality of RNA was assessed using an ND-1000
spectrophotometer (Nanodrop, Wilmington, DE) and qualified using an
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).
Agilent two color 60K Mouse microarrays were used to assess whole
genome gene expression according to the manufacturer’s instructions.
Control samples were labelled with Cy3 (green) and treated samples
were labelled with Cy5 (red). For background correction, the linear
models for microarray data (LIMMA) package (Ritchie et al., 2015) were
used within R 3.3.2 (RCoreTeam, 2016). Normalization within arrays
was conducted using the “Loess” function and normalization between
arrays was conducted using the “Aquantile” function (Smyth & Speed,
2003). The “lmscFit” function was used for separate channel analysis of
two-color microarray data (Smyth & Altman, 2013) using Benjamini-
Hochberg to adjust p values.
2.14 | Analysis of gene expression network models
To derive an interactome model for AMPA/CTZ and Garcinol treated
cells, differentially expressed genes were used as “seeds” and all known
protein/protein interactions between the seeds and their inferred
immediate neighbors were identified to generate a biological network
using the BioGRID model of the human Interactome (3.4.145; Chatr-
Aryamontri et al., 2015). Network generation and processing was per-
formed using Cytoscape 2.8.3 (Smoot, Ono, Ruscheinski, Wang, &
Ideker, 2011). A hierarchy of interacting network modules within the
interactome models was constructed using the ModuLand plugin for
Cytoscape 2.8.3 (Kovacs, Palotai, Szalay, & Csermely, 2010; Szalay-
Bek}o et al., 2012). The central core unit of each network module (meta-
node) was defined as the 10 most central genes. A list of the unique
genes in each metanode was generated and used as a model of the
functional core of the associated network for further comparison. The
String database was used to assess the integrity and connectivity of
gene modules (Szklarczyk et al., 2015).
2.15 | Data analysis and statistics
Normal distributions were tested using an online Shapiro-Wilks tool
(Dittami, 2009) and when present two-group comparisons were made
by t tests, and multiple comparisons examined by one-way ANOVA fol-
lowed by Tukey’s Honest Significance Difference post hoc tests.
Mann-Whitney U tests were used for two-group comparisons when
non-normal distributions were detected. All comparisons were tested
using the online tool VassarStats (Lowry, 2009). Potential regulators of
Gria4 were identified by screening all known Gria4 interactions (Inge-
nuity Pathway Analysis, Qiagen, Redwood City, CA). A fixed value of
pa < .05 for two-tailed tests was the criterion for reliable differences
between groups. One-tailed tests were used when predictions were
made possible by preceding results. Cited values ares 6 SEMs.
3 | RESULTS
3.1 | Expression of AMPAR subunits in oli-neu cells
Oli-neu cells are an established model for OPC (Jung et al., 1995;
Pereira, Dobretsova, Hamdan, & Wight, 2011) previously used to study
transcriptional regulation in oligodendroglia (Fratangeli et al., 2013).
AMPAR expression has not been reported in Oli-neu cells so we used
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qPCR and immunocytochemistry to detect AMPAR subunits GluA1–4.
qPCR detected transcripts for all four GluA subunits (data not shown).
Using immunofluorescent labeling GluA1 expression was limited to a
few cells in which expression was restricted to the nucleus (Supporting
Information Figure S1ai, S1aii). In contrast, GluA2, 3, and 4 were
expressed by all cells (GluA2–3, Supporting Information Figure S1bi,ci;
GluA4; Figure 1ai), with receptor subunits appearing in a punctate pat-
tern throughout the soma and cell processes (GluA2–3, Supporting
Information Figure S1bii,cii; GluA4, Figure 1aii). Although the permeabi-
lizing conditions required for penetration of these antibodies precluded
a definitive test of membrane expression, confocal optical sections
revealed GluA4 signal distributions characteristic of membrane localiza-
tion (Figure 1b). Further evidence for GluA4 membrane localization was
provided by optical sections from cells labeled with the CellMask plasma
membrane dye, where distinct GluA4 puncta colocalized with the mem-
brane signal (Figure 1c,d). To confirm that AMPAR subunits form func-
tional receptors in Oli-neu cells we measured AMPAR-mediated Ca21
fluxes with the genetically encoded Ca21 indicator GcAMP5. AMPA/
CTZ induced small transient elevations in intracellular Ca21 in 50% of
the cells examined (Supporting Information Figure S2a). These data sug-
gest that functional calcium-permeable AMPAR are present at modest
levels in Oli-neu cells. We examined the ability of these receptors to
mediate pathological signaling events by exposing Oli-neu cells to
AMPAR-stimulating treatments likely to induce excitoxicity. Log con-
centrations of L-glutamate (1–1,000 mM) applied for 5 hr reduced viabil-
ity from 10 mM (Supporting Information Figure S2b; ANOVA p < .0001,
control vs. 10 mM p < .05, control vs. 100 mM p < .01, control vs.
1,000 mM p < .01). We also examined viability after a 5-hr exposure to
AMPA/CTZ, which specifically and potently activates AMPAR without
affecting other types of glutamate receptor. This treatment was more
effective than L-glutamate, with effects observed at the lowest concen-
tration (1 mM; Figure 1e; ANOVA p < .0001, control vs. 1 mM p < .01,
control vs. 10 mM p < .01, control vs. 100 mM p < .01, control vs.
1,000 mM p < .01). Importantly, the decrease in cell viability caused by
AMPA/CTZ was blocked by pre-incubation in the selective AMPAR
antagonist NBQX (Figure 1f; ANOVA p < .01, AMPA/CTZ vs.
CTZ1NBQX p < .01, AMPA/CTZ vs. AMPA/CTZ1NBQX p < .01).
Prolonged stimulation with AMPA (200 mm) in the absence of CTZ
inhibits OPC proliferation and differentiation without affecting viability
(Yuan et al., 1998). We used this treatment, designated here as
AMPA24h, to determine if Oli-neu cells are similarly sensitive to milder
levels of AMPAR activation. AMPA24h had no effect on Oli-neu cell pro-
liferation (Supporting Information Figure S3a; p 5 .83), or cell viability
(Supporting Information Figure S3b; p 5 .38), showing that AMPA only
affected Oli-neu cells when co-treated with CTZ. Incubation with
100 mm AMPA/CTZ produced a reliable decrease in cell viability (Figure
1e), so this treatment was chosen for studies aiming to uncover mecha-
nisms regulating GluA4 transcription during excitotoxic injury.
3.2 | Identifying transcriptional regulators of Gria4
An in silico approach designed to identify regulators of Gria4 transcrip-
tion highlighted NF-Yb as a relevant target. Gria4 was previously
identified in a large-scale screen of NF-Yb binding sites carried out in
HEPG2 cells (Testa et al., 2005). This information, together with its
established role in controlling proliferation and cell death (Imbriano,
Gnesutta, & Mantovani, 2012), actions that are regulated in oligoden-
droglia by AMPAR, marked NF-Yb as a promising candidate for further
study. The human Gria4 gene was screened for locations showing
evidence of NF-Y binding. This search identified a candidate region
(chr11:105685481–105685873) in intron 4 where there was ChIP-seq
evidence from the ENCODE data analysis of the GM12878 cell line (a
lymphoblastoid line) that supported NF-Yb interactions with the DNA.
There was also evidence at the same location for the histone marks
H3K4Me1, often found near regulatory elements, and H3K27Ac, often
found near active regulatory elements, in GM12878 and a range of
other ENCODE cell lines. The identified region corresponded to
chr9:4,601,105-4,601,164 in intron 4 of the mouse Gria4 gene. A
search for putative NF-Yb binding sites (CCAAT) within this region of
the mouse genome identified three such sequences (termed sites 1–3
in this article, Supporting Information Table S2). This region is located
30 to the transcription start site (TSS) and so falls outside of the classic
proximal promoter position associated with CCAAT elements (Manto-
vani, 1999).
3.3 | Excitotoxic AMPAR stimulation decreased
expression of NF-yb and GluA4
Prolonged activation of AMPAR in pOPC cultures has been shown to
induce alterations in the expression of GluA4 protein (Hossain et al.,
2014). To probe possible mechanisms regulating Gria4 transcription,
we measured Gria4 and NF-Yb transcript and protein in Oli-neu cells
subjected to AMPA24h. Similar to our observations of cell viability and
proliferation, transcription of Gria4 and NF-Yb remained unaffected by
AMPA24h (Supporting Information Figure S4a,b; Gria4, p 5 .98; NF-Yb,
p 5 0.64). Levels of GluA4 (Supporting Information Figure S4ci,cii) and
NF-Yb (Supporting Information Figure S4ci,ciii) protein were also unaf-
fected by this AMPA treatment (GluA4, p 5 .75; NF-Yb, p 5 .86).
Given the modest extent of functional AMAPR expression in Oli-neu
cells we considered whether stronger AMPAR activation might be
required to modulate GluA4 expression. Indeed, treatment of Oli-neu
with AMPA/CTZ for 5 hr led to a significant reduction in the level of
Gria4 mRNA (Figure 2a; p < .05) and GluA4 protein (Figure 2ci,cii;
p < .001). Treatment with AMPA/CTZ also reduced the levels of NF-
Yb mRNA and protein (Figure 2b,di,dii) (NF-Yb mRNA, p < .05; NF-Yb
protein, p < .04), suggesting that levels of Gria4 expression may be
related to those of NF-Yb.
3.4 | Excitotoxic AMPAR stimulation decreased
enrichment of NF-yb at Gria4 binding sites
The corresponding changes in NF-Yb and Gria4 detected after
AMPA/CTZ (Figure 2) may indicate that both genes are targets of
the same regulator, or that NF-Yb directly regulates Gria4. We per-
formed ChiP assays directed at CCAAT sites 1–3 (Supporting Infor-
mation Table S3) to determine whether NF-Yb physically interacted
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with these CCAAT sites, and if binding was modulated by excito-
toxic injury. Treatment with AMPA/CTZ resulted in a significant
reduction in NF-Yb enrichment at sites 1 (p < .0001; Figure 3a)
and 2 (p < .01; Figure 3b) but not site 3 (data not shown). In
agreement with our analysis of Gria4 transcription (Supporting
Information Figure S3), AMPA24h treatment had no effect on NF-
Yb binding (sites 1 and 2; Figure 3c,d; site 3 data not shown; site
1, p 5 .63; site 2, p 5 .31). The observed decrease in Gria4
FIGURE 1.
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transcription following AMPA/CTZ (Figure 2a), and the ChIP data,
suggested that NF-Yb-Gria4 interactions play an important role in
the regulation of Gria4 transcription.
3.5 | Pharmacological inhibition of NF-Y reduced NF-
yb function and triggers apoptotic cell death
The data presented above indicate NF-Y as a regulator of Gria4 tran-
scription during excitotoxic injury. Further support for this idea was
sought by performing pharmacological experiments to disrupt NF-Y
activity in Oli-neu cells. NF-Y function depends on interactions
between NF-Yb and the nuclear co-activator protein p300 (Figure 4a;
Faniello et al., 1999). Therefore, we used the p300 inhibitor Garcinol
(Balasubramanyam et al., 2004) to examine the impact of reduced NF-
Y function on Gria4 transcription. The effect of Garcinol on oligoden-
droglia has not been reported previously. As described in Materials and
Methods concentrations of Garcinol >10 mM produced widespread cell
death with the majority of cells detaching from the dish within 5 hr of
application. At 10 mM the majority of Oli-neu remained attached to the
dish, and a Trypan blue assay indicated a significant reduction in Oli-
neu viability (Figure 4b; p < .01). Moreover, this concentration of Gar-
cinol also reduced transcription of NF-Yb (Figure 4c; p < .05) and Gria4
(Figure 4d; p < .05). To test if reduced NF-Y function associated with
alterations in Gria4 expression, we examined enrichment of NF-Yb at
Gria4 CAAT sites 1–3 following Garcinol treatment. Garcinol decreased
NF-Yb binding to at CAAT sites 1 and 2 (Figure 4e,f; site 1, p < .05;
site 2, p < .05), but not 3 (data not shown). These data confirm that
Garcinol induced the same changes in NF-Yb/Gria4 interactions, and
Gria4 transcription to those observed after AMPAR-mediated excito-
toxicity. To determine if disruption of NF-Ywas associated with apo-
ptosis, we examined nuclear labeling for cleaved caspase-3 following a
5-hr Garcinol treatment. 24 hr after this treatment cleaved caspase-3
was undetectable in vehicle treated cells (Figure 4gi,gii), but could be
observed in the cytoplasm and nuclei of Oli-neu cells exposed to Garci-
nol (Figure 4giii,giv). The % of cleaved caspase-31 cells was 25% (Fig-
ure 4h), suggesting caspase-3-dependent apoptosis.
3.6 | NF-yb knockdown reduced transcription of
constructs containing the Gria4 regulatory region
To test the influence of NF-Y on the CCAAT-containing regulatory
region we performed reporter assays on Oli-neu cells transfected with
the wtGria4 construct (Supporting Information Table S3) and either
siNF-Yb or siControl. Knockdown of NF-Yb reduced reporter activity
from the wtGria4 construct by 54% relative to siControl transfected cells
(Figure 5a; p < .0001). To verify the efficiency of the knockdown, we
measured NF-Yb transcripts 24 hr after transfection with siNF-Yb. Oli-
neu cells transfected with siNF-Yb displayed a 64% reduction in NF-Yb
mRNA compared with cells transfected with siControl (Figure 5b;
p < .01). NF-Yb knockdown also reduced the level of Gria4 transcription
(Figure 5c; p < .05) further supporting a role for NF-Y in the control of
Gria4 expression. We sought additional evidence for the involvement of
NF-Y inGria4 transcription by generating a reporter construct containing
mutations in NF-Yb binding sites 1–3 (DGria4, Supporting Information
Table S3). In contrast toNF-Yb knockdown, cells transfectedwithDGria4
exhibited a 27.6-fold increase in activity of the reporter compared with
cells treatedwith thewtGluA4 construct (Figure 5d; p< .01).
3.7 | NF-yb regulates Gria4 expression and cell
survival in primary OPC
Experiments were performed to determine if the molecular and cellular
results obtained in Oli-neu cells reflect the role of NF-Yb in pOPC. In
agreement with the data from Oli-neu cells, knockdown of NF-Yb (Fig-
ure 6ai) produced a significant reduction in levels of Gria4 (Figure 6aii;
p < .05). Similarly, NF-Yb knockdown was associated with a reduction
in OPC viability (Figure 6b; p < .05) that mirrored the effect observed
following pharmacological inhibition of NF-Yb by Garcinol (Figure 4b).
Treatment with AMPA/CTZ also reduced the viability of pOPC (Figure
6c; p < .05). However, in pOPC excitotoxic injury produced an increase
in the levels of both NF-Yb (Figure 6di; p < .01) and Gria4 (Figure 6dii;
p < .01) mRNA. Thus, while the relationship between NF-Yb and Gria4
was maintained, the direction of change in pOPC opposed that
observed in Oli-neu cells.
3.8 | Transcriptomic analysis indicated similar effects
of AMPA/CTZ and garcinol on apoptotic genes
Our RNAi and pharmacological data suggest a role for NF-Y in the regu-
lation of OPC survival. This conclusion agrees with findings from other
cell types regarding the role of NF-Y in the regulation of apoptosis and
viability (Benatti et al., 2008; Jiang et al. 2015; Morachis et al. 2010;
Mojsin et al. 2015). To explore the wider context of the downstream
functions associated with NF-Y in oligodendroglia we performed a
FIGURE 1 GluA4 expression and AMPAR-mediated excitotoxicity in Oli-neu cells. (a) Immunofluorescent labeling for GluA4 in Oli-neu cells.
(ai) Merged images for GluA4 (green), and DAPI (blue) at 203. (aii) 1003 image revealed punctate nature of GluA4 expression. (b) Sequen-
ces of confocal sections (1003; 0.2 mm) revealed GluA4 signal distribution consistent with plasma membrane localization (c) Membrane
localization of GluA4. (ci) Faint immunofluorescent signal (green) from control sample incubated in secondary antibody alone. (cii) Merged
image revealing no appreciable colocalization of the control secondary antibody stain with CellMask plasma membrane signals (red). (di) Dis-
tinct GluA41 puncta (green) in a sample incubated with anti-GluA4. (dii) Clear colocalization (yellow pixels) of GluA4 (green) and CellMask
(red) signals in the cell depicted in di. (e) Prolonged activation of AMPAR caused a dose-dependent reduction in Oli-neu cell viability. Cell
viability (% of viable cells normalized to DMSO treated controls) declined significantly after 5 hr exposure to 1 mM (74.6% 6 1.1%), 10 mM
(69.7% 6 1.9%), 100 mM (54.8% 6 3.0%) and 1,000 mM (44.1% 6 1.5%) AMPA/CTZ. (f) NBQX prevented excitotoxicity in Oli-neu cells.
AMPA/CTZ induced an increase in Trypan blue1 cells (2.54 6 0.35-fold increase over NBQX/CTZ control) that was prevented by the
AMPAR antagonist NBQX (0.93 6 0.04-fold increase over NBQX/CTZ control). Scale bars in a 5 20 mm. Scale bars in b and c 5 10 mm. **
Significance p < .01. Data expressed as means 6 SEM [Color figure can be viewed at wileyonlinelibrary.com]
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transcriptomic study in Oli-neu cells subjected to excitotoxic injury and
pharmacological disruption of NF-Y. The top 500 differentially
expressed genes ranked by p value (p < .001) from the two injury treat-
ments (AMPA/CTZ and Garcinol) were used to generate interactome
models (Supporting Information Tables S4 and S5). The central hierar-
chy of each interactome model (top 30 gene modules) was determined
using the Moduland algorithm (Supporting Information Tables S6 and
S7). Comparison of central interactome hierarchies identified 39 com-
mon genes (p < .0001; Figure 7a). Control of apoptosis was associated
with 17 of these 39 genes (p 5 1.1 3 10210; rounded squares in Figure
7b,c – Supporting Information Table S8). The shared network of 39
genes was more connected than expected by chance (p < .001) and a
central element was identified (dashed blue ellipse in Figure 7b,c) in
which treatments induced identical differential gene expression.
FIGURE 2 Treatment with AMPA/CTZ decreased expression of GluA4 and NF-Yb. (a and b) Transcript levels for Gria4 (a) and NF-Yb (b)
were significantly reduced by a 5-hr exposure to AMPA/CTZ (Gria4: Control 1.00 6 0.03, AMPA 0.51 6 0.15; NF-Yb: Control 1.01 6 0.11,
AMPA 0.60 6 0.06). (c and d) Western blot analysis from Oli-neu cells treated with AMPA/CTZ. (ci and di) Representative immunoblots for
GluA4 (ci), NF-Yb (di) and the loading control protein a-tubulin from four independent experiments. (cii and dii) Densitometric analysis of
immunoblots shown above (normalized against a-tubulin) indicated reduced levels of GluA4 (cii) and NF-Yb (dii) protein after exposure to
AMPA/CTZ (GluA4: Control 1.00 6 0.05, AMPA 0.76 6 0.04; NF-Yb: Control 1.00 6 0.12, AMPA 0.69 6 0.08). * and ** Significance
p < .05 and p < .01, respectively, # significance p < .05 one-tailed. Data expressed as means 6 SEM
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FIGURE 3 Treatment with AMPA/CTZ but not AMPA24h altered binding of NF-Y to Gria4. (a and b) ChIP assays indicated a significant reduc-
tion in enrichment of NF-Yb at CCAAT sites 1 (a) and 2 (b) after treatment with AMPA/CTZ. (ai and bi) show RT-PCR gels for four independent
experiments on sites 1 and 2, respectively. I, input signal; O, output signal; Con, control; A/C, AMPA/CTZ. (aii and bii) Quantification of NF-Yb
enrichment at sites 1 and 2, respectively (normalized to control average). Treatment with AMPA/CTZ significantly reduced binding of NF-Yb at
site 1 (CTZ control 1.006 0.12, AMPA/CTZ 0.316 0.07) and site 2 (CTZ control 1.006 0.14, AMPA/CTZ 0.216 0.04). (c and d) ChIP assays
showing unaltered levels of NF-Yb at CCAAT sites 1 (c) and 2 (d) on the Gria4 promoter after AMPA24h. (ci and di) show RT-PCR gels for four
independent experiments on sites 1 and 2, respectively. I, input signal; O, output signal; Con, control; A24h, AMPA24h. (cii and dii) Quantification
of NF-Yb enrichment at site 1 (normalized to control average) (CTZ control 1.006 0.35, AMPA/CTZ 0.926 0.59) and site 2 (CTZ control
1.006 0.30, AMPA/CTZ 0.636 0.16). *** Significance p < .0001. Data expressed as means6 SEM
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4 | DISCUSSION
In this work, we used excitotoxic levels of AMPAR stimulation to
uncover mechanisms regulating the expression of GluA4 in cells of the
oligodendrocyte lineage. We identified an intronic regulatory region
harboring binding sites for NF-Yb, whose binding by this transcription
factor are down-regulated during excitotoxic injury. Decreased NF-Yb
binding is accompanied by a reduction in the levels of GluA4 mRNA
and protein, an effect mimicked at the transcriptional level by siRNA
knockdown of NF-Yb. We also show that reducing NF-Y function
through pharmacological inhibition and knockdown compromises the
survival of Oli-neu and pOPC respectively, and that reduced NF-Y
FIGURE 4.
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function alters the expression of a number of apoptotic genes.
Together, these data provide the first example of a trans-acting mecha-
nism controlling Gria4 expression, and highlight the NF-Y pathway as a
regulator of OPC viability and survival.
4.1 | Studying transcriptional regulation of AMPAR in
oli-neu cells
Oli-neu cells have been used to study aspects of oligodendrocyte biol-
ogy including myelin protein trafficking (Dhaunchak, Colman, & Nave,
2011; Trajkovic et al., 2006), exosome release (Fr€uhbeis et al., 2013),
and the expression and function of connexins (Sohl, Hombach, Degen,
& Odermatt, 2013) and G protein coupled receptors (Fratangeli et al.,
2013; Simon et al., 2016). The ease of generating large, high purity, cul-
tures of these cells, and their ease of transfection relative to pOPC,
make them particularly useful for studies of transcript expression and
regulation where large numbers of homogenous cells must be manipu-
lated and harvested for mRNA and protein sampling (Gobert et al.,
2009; Iacobas & Iacobas, 2010; Joubert et al., 2010). In this regard,
their utility as a model for OPC biology is further supported by data
from the present study showing that alterations in NF-Y function
induce produces similar effects on Gria4 transcription and cell viability
in both Olie-neu and pOPC.
The expression and regulation of glutamate receptors has not been
explored in Oli-neu cells, although this was examined in electrophysio-
logical studies of the closely related cb-neu cell line (Jung et al., 1995),
in which the absence of membrane currents was reported following
exogenous application of glutamate. In contrast, the present paper pro-
vides two independent lines of evidence (Ca21 imaging and excitotoxic
cell death) that suggest modest levels of functional AMPAR expression
in Oli-neu. Despite these low levels of AMPAR function, Oli-neu cells
proved useful for detecting excitotoxic changes in GluA4 subunit
expression and the transcriptional machinery controlling these
processes.
4.2 | Excitotoxicity-induced changes in Gria4
transcription in olie-neu and pOPC
Depending on the cell type examined, excitotoxic injury either
decreased (Oli-neu) or increased (pOPC) transcription of Gria4. These
data from pOPC reflect those from an in vivo study of GluA4 expres-
sion in neonatal rats exposed to hypoxia (Sivakumar, Ling, Lu, & Kaur,
2010). Here, exposure to hypoxia that induces strong elevations in the
concentration of extracellular glutamate is associated with a significant
increase in GluA4 immunoreactivity within immature oligodendroglia.
The expression of Gria4 is regulated developmentally (Itoh et al., 2002;
Hossain et al., 2014), thus the direction of excitotoxicity-induced regu-
lation of Gria4 in oligodendroglia may depend on maturational status.
Indeed, Oli-neu cells cultured under the conditions used in the present
study exhibit low levels of immunoreactivity to anti-O4 (Toutouna
et al., 2016), suggesting that this cell line holds a more immature posi-
tion in the lineage than pOPC, which typically exhibit strong anti-04
staining. This difference not withstanding, other aspects of the relation-
ship between NF-Yb, Gria4 transcription and cell viability were vali-
dated in pOPC, supporting a role for NF-Yb in the regulation of Gria4
and cell survival in OPC.
4.3 | Characteristics of the intronic CCAAT regulatory
region in mouse Gria4
The CCAAT box is a common promoter element occupying a position
typically located between 260 and 2100 from the TSS (Mantovani,
1999), where it exerts well-described actions on promoter activity (Dol-
fini, Gatta, & Mantovani, 2012). Prior to the present work NF-Y had
not been studied in oligodendroglia. However, CCAAT sites located in
the promoter of protein zero, a key myelin gene in the peripheral nerv-
ous system, regulate protein zero transcription in Schwann cells (Brown
& Lemke, 1997). The CCAAT sites identified in the present paper are
located 30 to the Gria4 TSS so fall outside of the proximal promoter
region. These observations add to a growing body of evidence demon-
strating roles for NF-Y outside of classic promoter regions. For exam-
ple, a recent genome-wide mapping study revealed that 25% of NF-Y
peaks are associated with distal enhancer regions (Fleming et al., 2013).
In addition, expression arrays performed following NF-Ya inactivation
revealed that 50% of differentially expressed genes exhibit NF-Y/DNA
binding outside of promoter regions. The importance of NF-Y/
enhancer interactions have also been validated in vivo, where they are
found to regulate tissue specific expression of Hoxb4 during embryonic
development (Gilthorpe et al., 2002).
FIGURE 4 Garcinol reduced cell viability, NF-Yb transcription and NF-Yb Gria4 interactions. (a) Model illustrating organization of the NF-Y
complex, it’s association with CCAAT sites, and regulation through Garcinol sensitive p300 (Faniello et al., 1999). (b) Garcinol reduces Oli-
neu cell viability. Cell viability normalized to the control treatment was reduced following a 5-hr treatment with Garcinol (10 mM; control
1.00 6 0.02, Garcinol 0.88 6 0.01). (c) Transcript levels for NF-Yb were significantly reduced by a 5-hr exposure to Garcinol (control
1.00 6 0.15, Garcinol 0.55 6 0.06). (d) Garcinol reduced levels of GluA4 transcripts (control 1.00 6 0.19, Garcinol 0.51 6 0.06). (e and f)
Treatment with Garcinol disrupted binding of NF-Y to the Gria4 promoter. Top panels show RT-PCR gels for four independent experiments
on sites 1 (e) and 2 (f). I, input signal; O, output signal; Con, control; G, Garcinol. Lower panels show quantification of NF-Yb enrichment at
sites 1(e) and 2 (e). Enrichment of NF-Yb at both sites was significantly reduced following treatment with Garcinol at site 1 (control
1.00 6 0.25, Garcinol 0.16 6 0.08) and site 2 (control 1.00 6 0.19, Garcinol 0.25 6 0.12). (g) Representative cleaved Caspase-31 immuno-
staining (green) with DAPI (blue) in Oli-neu cells after 24-hr treatment with DMSO vehicle (gi and gii) and Garcinol (giii and giv). White
arrowheads indicate locations with cleaved Caspase31 immunofluorescence within the nucleus indicative of apoptosis. (h) Cleaved caspase-
31 was undetectable in control treated cells, but was observed in 25% of cells after Garcinol treatment. * and ** Significance p < .05 and
p < .01 respectively, # significance p < .05 one-tailed. Scale bars in f 50 mm. Data expressed as means 6 SEM [Color figure can be viewed
at wileyonlinelibrary.com]
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FIGURE 5 Knockdown of NF-Yb altered the influence of Gria4 regulatory region and Gria4 transcription. (a) Activity of a reporter construct
harboring wtGria4 NF-Y sites (normalized to control averages) from Oli-neu cells transfected with siControl and siNF-Yb. Reporter activity
was reduced in cells transfected with siNF-Yb (siControl 1.00 6 0.05, siNF-Yb 0.57 6 0.06). (b and c) Transcript levels (normalized to con-
trol averages) for NF-Yb (b) and Gria4 (c) were significantly reduced in cells transfected with siNF-Yb (NF-Yb: siControl 1.00 6 0.11, siNF-
Yb 0.36 6 0.09; GluA4: siControl 1.00 6 0.12, siNF-Yb 0.55 6 0.04). (d) Luciferase reporter activity (normalized to control averages) from
Oli-neu cells transfected with wtGria4 and DGria4 constructs. Reporter activity (normalized to wtGluA4 control average) was significantly
enhanced by mutations of the NF-Y sites (wtGluA4 1.00 6 0.08, DGluA4 27.62 6 2.33). *, **, *** Significance p < .05, p < .01 and
p < .001 respectively. Data are expressed as means 6 SEM
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FIGURE 6 NF-Yb regulates Gria4 transcription and cell survival in primary OPC. (ai) Transfection of pOPC with a cocktail of four siRNA
targeted against NF-Yb produces a significant reduction in NF-Yb mRNA (siControl 1.00 6 0.1, siNF-Yb multi 0.34 6 0.02). (aii) Knockdown
of NF-Yb leads to a significant reduction in Gria4 mRNA relative to siControl levels (siControl 1.00 6 0.07, siNF-Yb multi 0.75 6 0.02). (b)
Knockdown of NF-Yb reduces pOPC cell viability. pOPC viability normalized to siControl values was reduced 24 hr after transfection with
siNF-Yb multi (siControl 100 6 2.73, siNF-Yb multi 84.99 6 5.01). (c) Excitotoxic treatment compromises the viability of pOPC. The propor-
tion of viable pOPC (normalized to CTZ control) is significantly reduced after 5 hr of AMPA/CTZ (CTZ control 100 6 2.00, AMPA/CTZ
78.25 6 2.33). (di and dii) Excitotoxic stimulation increases transcription of NF-Yb and Gria4 relative to CTZ control levels (NF-Yb: CTZ con-
trol 1.00 6 0.01, AMPA/CTZ 1.57 6 0.10; Gria4: CTZ control 1.03 6 0.10, AMPA/CTZ 2.25 6 0.17). *, **, ** Significance p < .05, p < .01,
and p < .001, respectively. Data are expressed as means 6 SEM
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Excitotoxic injury reduced NF-Yb binding to CCAAT sites located
within the Gria4 intronic regulatory region and produced a parallel
reduction in the level of Gria4 transcripts. In agreement with this, our
functional studies using a reporter construct containing the Gria4 regu-
latory regions showed that knockdown of NF-Yb reduced activity of a
minimal promoter. Overall these data from qPCR, ChiP and reporter
assays are consistent with a role for NF-Y in regulating Gria4 transcrip-
tion in Oli-neu cells. We also examined NF-Y actions at these sites
using a reporter construct bearing mutations designed to prevent NF-Y
binding. Surprisingly, these mutations led to a significant increase in
reporter activity. Knockdown of NF-Yb had no effect on promoter
activity when the Gria4 region was absent. Thus, the opposing actions
of the NF-Y site mutations and siRNA knockdown, cannot be explained
on the basis of NF-Y actions on sequences located outside of the regu-
latory region. These results could be explained if mutation of the bind-
ing sites hindered the actions of another repressive trans-acting factor
that exerts actions on the promoter via the CCAAT elements. Indeed,
the high abundance of H3K27Ac marks in this region of Gria4 suggests
it is highly regulated. One possible candidate is the CCAAT/enhancer
binding proteins (C/EBPs), which have a well described ability to bind
CCAAT boxes (Landschulz, Johnson, Adashi, Graves, & McKnight,
1988). Irrespective of these possibilities, the knockdown, qPCR and
ChIP experiments presented in this paper highlight NF-Yb as an effec-
tive regulator of Gria4 transcription.
4.4 | First trans-acting mechanism regulating GluA4:
Implications for protective therapies
To our knowledge, the actions of NF-Yb reported in the present study
describe the first trans-acting mechanism controlling GluA4 expression.
Earlier work examining the promoter of rat Gria4 described two poten-
tial regulatory regions (Borges, Myers, Zhang, & Dingledine, 2003). The
first was a long interspersed element (LINE) located 3.6–3.9 kb
upstream from the translation start site (TSS), which was found to con-
tain silencing elements. This work also identified several TSS in Rat
Gria4 located between 21,090 and 21,011. Importantly, the LINE
silencing region is distant from these sites being 2–3 kb further
upstream, and so contrasts greatly with the regulatory region we have
described in mouse Gria4, which is located 30 of the TSS. The second
regulatory region in Rat Gria4 contained a cluster of transcription factor
sites (e.g., SP1, CAAT box, IK2, MRE) located close to the TSS (Borges
et al., 2003). Although the authors did not determine the influence of
these sites on transcription directly, they suggested their involvement
in directing neuronal selectivity since deletion of the 177 bp region
containing them reduced transcription of Gria4 in neuronal, but not glial
cultures.
New data from the present study indicate that NF-Y plays an
important role in the response of oligodendroglia to cellular stress.
Both excitotoxic injury and a pro-apoptotic treatment with Garcinol ini-
tiated a change in NF-Y function that was tightly linked to alterations
in Gria4 transcription. Reduced levels of GluA4 could protect oligoden-
drocytes from further injury by diminishing the supply of calcium-
permeable subunits for assembly into AMPAR. In contrast, recent
FIGURE 7 Interactome modelling from AMPA/CTZ and Garcinol
treatments identified a core network element with consistent
differential gene expression. (a) Overlap of the central network
hierarchies identified by the moduland algorithm (numbers of genes).
A network of the common 39 differentially regulated genes was
defined using the STRING database (confidence > 0.4) in Oli-neu
cells treated with AMPA/CTZ (b) and Garcinol (c). Blue5 inferred
interaction; green5 down regulated; red5 up regulated gene expres-
sion with Oli-neu cell treatments. Shade of green/red indicate level
of fold change. Rounded squares5 genes associated with control of
apoptosis. All differential gene expression p < .01 [Color figure can
be viewed at wileyonlinelibrary.com]
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findings indicating a role for AMPAR subunits GluA2, 3, and 4 in OPC
survival (Kougioumtzidou et al., 2017) suggest that an increase in Gria4
transcription, as observed in pOPC following excitotoxic treatment,
may promote viability. Given this complexity, further studies are
required to determine the potential of Gria4 modulation to promote
OPC viability under excitotoxicity-inducing conditions such as hypoxic-
ischemia (Follett et al., 2000) and CNS inflammation (Groom et al.,
2003; Kanwar et al., 2004; Pitt et al., 2000).
4.5 | Involvement of NF-Y in cell death
Both excitotoxic injury and pharmacological inhibition of NF-Y reduced
the function of this transcription factor and compromised viability in
Oli-neu cells, while siRNA-mediated knockdown of NF-Yb similarly
reduced viability in cultures of pOPC. Disruption of NF-Y function also
induced apoptosis and regulated a core group of apoptotic genes that
were similarly regulated by excitotoxicity. Together these findings sug-
gest a link between NF-Y, oligodendroglial survival, and the regulation
of genes controlling apoptosis. In agreement with this, a number of
reports provide evidence for the involvement of NF-Yb in anti-
apoptotic actions. For example, NF-Yb knockdown in a colorectal carci-
noma cell line (HCT116) induces apoptosis through reductions in the
anti-apoptotic genes Bcl-2 and BI-1 (Benatti et al., 2008). ChIP assays
and luciferase reporter experiments show that Bcl-2 and BI-1 are tar-
gets of NF-Yb and that reduced NF-Y function decreases transcription
of these genes, indicating that NF-Yb directs the activation of these
anti-apoptotic genes (Benatti et al., 2008). In the same study it was
reported that reduction of NF-Yb leads to increased acetylation of p53,
a condition that promotes apoptosis via increased p53 binding to pro-
apoptotic targets Bax and Mdm2. Thus, NF-Yb may regulate the apo-
ptotic response of cells by controlling the balance between pro- and
anti-apoptotic pathways. In line with this idea, recent work in a human
osteosarcoma cell line (U2OS) identified NF-Yb as a direct target of
pro-apoptotic E2F1 (Jiang, Nevins, Shats, & Chi, 2015). Importantly,
knockdown of NF-Yb enhances E2F1-mediated activation of pro-
apoptotic targets and increases apoptosis.
Increasing expression of NF-Yb may not promote survival under all
conditions of cellular stress. For example, the pro-apoptotic FAS/APO1
gene is a direct NF-Y target, whose expression in a breast cancer cell
line (MCF7) is enhanced by both apoptotic DNA damage, and the
forced expression of NF-Y proteins (Morachis, Murawsky, & Emerson,
2010). Similarly, forced transduction of carcinoma cell line NT2/D1
with NF-Ya proteins reduces cellular growth by inducing a decrease in
their survival (Mojsin, Topalovic, Marjanovic Vicentic, & Stevanovic,
2015). The relationship between NF-Y function and cell viability there-
fore appears to be complex, with the effects of loss and gain of NF-Y
function varying under different cellular and molecular contexts. Our
experiments in pOPC revealed an increase in the transcription of NF-
Yb following excitotoxic injury, yet, at the same time knockdown of
NF-Yb decreased their viability, as did excitotoxic injury in Oli-neu.
Although appearing contradictory, these outcomes are consistent
within the framework of NF-Y function discussed above, where roles
in the regulation of both pro- and anti-apoptotic responses have been
described (Gatta, Dolfini, & Mantovani, 2011). Importantly, the present
data clearly show that dysregulation of NF-Yb consistently associates
with reduced pOPC viability; therefore the direct modulation of NF-Y
function is unlikely to provide a viable strategy for protecting OPC
from excitotoxic injury.
Alterations in NF-Y function per se are likely to compromise OPC
survial in vivo, therefore we performed a network analysis on gene
expression microarrays to examine the transcriptional events associ-
ated with NF-Y in oligodendroglia. This analysis in Oli-neu subjected to
excitotoxic injury and pharmacological disruption of NF-Y revealed that
43% of the genes commonly regulated in these models were associated
with the regulation of apoptosis. On this basis these genes, and their
downstream effectors, may provide promising targets for future work
aiming to identify targets capable of protecting OPC from excitotoxic
injury without compromising other essential NF-Y functions.
4.6 | Involvement of NF-Y in CNS dysfunction
As discussed above our data suggest an important role for NF-Y func-
tion in OPC survival. This conclusion is complemented by studies indi-
cating NF-Y deregulation as a contributor to neurodegenerative
processes in several polyglutamine (polyQ) expansion diseases (Huang,
Ling, Yang, Li, & Li, 2011; Katsuno et al., 2010; Yamanaka et al., 2008).
In each case, disrupted NF-Y activity is associated with the accumula-
tion of mutated polyQ-bearing proteins. Neurodegeneration then pro-
ceeds, in part, due to alterations in the transcription of NF-Y targets
required for neuronal survival. This is exemplified in spinal and bulbar
muscular atrophy, a polyQ disorder involving the accumulation of
mutated androgen receptor (AR) protein in brain stem and spinal cord
motorneurons. In this condition transcription of transforming growth
factor-ß receptor type-II (TGFßR-II), a pro-survival NF-Y target, is
impaired due to abnormal associations between NF-Y and mutated AR
that probably prevent NF-Y from binding and activating TGFßR-II (Kat-
suno et al., 2010). Similarly, mutant Huntington, the pathological pro-
tein underlying Huntington’s Disease (HD), forms inappropriate
interactions with NF-Y leading to reduced transcription of heat shock
protein 70 (HSP70), an NF-Y target expected to aid in the clearance of
mutated proteins. These links between NF-Y dysfunction and CNS
pathology and our present data suggesting anti- and pro-survival roles
in oligodendroglia, highlight NF-Y dysfunction as an interesting target
for evaluation in pathological conditions involving oligodendrocyte and
myelin degeneration, including those mediated through excitotoxic
injury (Groom et al., 2003; Kanwar et al., 2004; Pitt et al., 2000).
In conclusion, this work identifies NF-Yb as a key controller of
Gria4 expression in OPC. AMPA-type glutamate receptors exert a
powerful influence on the development and survival of OPC (Fannon
et al., 2015; Gallo et al., 1996; Kougioumtzidou et al., 2017; Yuan et al.,
1998), and are themselves under strong developmental regulation
(Hossain et al., 2014; Itoh et al., 2002), thus further work exploring the
interplay between NF-Y function and OPC differentiation represent a
promising line of enquiry for studies aiming to uncover novel mecha-
nisms regulating myelination. This work also highlights the NF-Y sys-
tem as an important regulator of OPC survival during excitotoxic injury.
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OPC are exquisitely vulnerable to hypoxic-ischemic conditions (Back
et al., 2002; Back et al., 2001; Back & Rosenberg, 2014). Therefore, we
consider the NF-Y network as an interesting focus for future work aim-
ing to identify novel therapeutic targets for the protection of OPC dur-
ing excitotoxic injury.
5 | ORIGINAL DATA FILES
The transcriptomics data discussed in this publication including the
complete single channel analysis are available at the following URL:
http://epapers.bham.ac.uk/3088/).
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